Extensive psoriasis induced by pegylated interferon: a case report
2007

Psoriasis Induced by Pegylated Interferon: A Case Report

Sample size: 1 publication Evidence: low

Author Information

Author(s): Citro Vincenzo, Fristachi Raffaele, Tarantino Giovanni

Primary Institution: U.O.C. of General Medicine, Hepatological Unit, 'Mauro Scarlato' Hospital, Scafati (SA), Italy

Conclusion

The patient's psoriasis worsened during treatment with Pegylated Interferon but completely receded after therapy was stopped.

Supporting Evidence

  • The patient had no history of psoriasis before treatment.
  • Psoriasis developed during the third month of Pegylated Interferon therapy.
  • The psoriasis worsened to over 75% of body involvement during treatment.
  • The patient's liver enzyme levels normalized during the treatment.
  • Psoriasis completely receded one month after stopping the therapy.

Takeaway

A woman treated for hepatitis C developed psoriasis while on medication, but it went away completely after she finished her treatment.

Methodology

The patient was treated with Pegylated Interferon and Ribavirin for 24 weeks, with monitoring of liver enzyme levels and viral load.

Limitations

This is a single case report, limiting the generalizability of the findings.

Participant Demographics

50-year-old woman with chronic hepatitis C.

Digital Object Identifier (DOI)

10.1186/1752-1947-1-86

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication